P876: ANCHOR (OP-104): MELFLUFEN PLUS DEXAMETHASONE AND DARATUMUMAB OR BORTEZOMIB IN RELAPSED/REFRACTORY MULTIPLE MYELOMA—FINAL EFFICACY AND SAFETY RESULTS

• Enrique Maria Ocio San Miguel,
• Yvonne A. Efebera,
• Roman Hájek,
• Jan Straub,
• Vladimir Maisnar,
• Jean-Richard Eveillard,
• Lionel Karlin,
• Maria-Victoria Mateos,
• Albert Oriol,
• Vincent Ribrag,
• Paul Richardson,
• Stefan Norin,
• Jakob Obermüller,
• Nicolaas A. Bakker,
• Ludek Pour

Affiliations

Enrique Maria Ocio San Miguel

1 University Hospital Marqués de Valdecilla (IDIVAL), University of Cantabria, Santander, Spain

Yvonne A. Efebera

2 Blood and Marrow Transplant and Cellular Therapy, Ohio Health, Columbus, United States

Roman Hájek

3 University Hospital Ostrava, Department of Hemato-oncology, Ostrava, Czech Republic

Jan Straub

4 Všeobecná fakultní nemocnice, Prague, Czech Republic

Vladimir Maisnar

5 Charles University Hospital and Faculty of Medicine Hradec Králové, Hradec Králové, Czech Republic

Jean-Richard Eveillard

6 Hôpital Morvan, Brest, France

Lionel Karlin

7 Centre Hospitalier Lyon-Sud, University Claude Bernard Lyon 1,, Department of Hematology, Pierre-Benite, France

Maria-Victoria Mateos

8 Hospital Clinico Universitario de Salamanca/IBSAL/CIC, Salamanca, Spain

Albert Oriol

9 Institut Català d’Oncologia and Josep Carreras Research Institute, Hospital Germans Trias i Pujol, Badalona, Spain

Vincent Ribrag

10 DITEP, Gustave Roussy, Université Paris-Saclay, Villejuif, France

Paul Richardson

11 Dana-Farber Cancer Institute, Harvard Medical School, Boston, United States

Stefan Norin

12 Oncopeptides AB, Stockholm, Sweden

Jakob Obermüller

12 Oncopeptides AB, Stockholm, Sweden

Nicolaas A. Bakker

12 Oncopeptides AB, Stockholm, Sweden

Ludek Pour

13 University Hospital Brno, Brno, Czech Republic